metricas
covid
Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition)
ISSN: 2444-3824

Gastroenterology and Hepatology is the first journal to cover the latest advances in pathology of the gastrointestinal tract, liver, pancreas, and bile ducts, making it an indispensable tool for gastroenterologists, hepatologists, internists and general practitioners. In addition to the rigorously selected, systematically peer-reviewed manuscripts published in the research sections (Original Articles, Scientific Letters, Editorials, and Letters to the Editor), the journal also contains other important sections, such as Review Articles and Clinical Decision-Making Support, which offer in-depth reviews and updates on issues relating to the specialty.

See more Open Access Option

Indexed in:

SCIE/Journal of Citation Reports, Index Medicus/Medline, Excerpta Medica/EMBASE, SCOPUS, CANCERLIT, IBECS

See more

Follow us:

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2023
2.2
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2023
1.5
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2023
0.263
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2023
0.306
View more metrics
Hide
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease
Marta Calvo Moya, Francisco Mesonero Gismero, Cristina Suarez Ferrer, Alejandro Hernández-Camba, Danízar Vásquez Carlón, Fátima García Benasach, Mariam Aguas Peris, Francisco José Delgado Oliva, ... on behalf of GETECCU
Full text access
Open Article
Available online 12 July 2024
Clinical and manometric results of peroral endoscopic myotomy in patients with achalasia: Experience in a Latin American reference center
Angélica Tobón, Gustavo Rafael Cantillo Nassar, Albis Cecilia Hani, Nancy Muriel Herrera Leaño, Cristiam Pulgarin, Oscar Mauricio Muñoz
Available online 11 July 2024
Endocytoscopy of muscularis propria in rapidly evolving achalasia and recurrence of post-Heller achalasia
Hugo Uchima, Raquel Muñoz-González, Íngrid Marín, Noemí Caballero, Claudia Cepero, Ignacio Iborra, Juan Colán-Hernández, Edgar Castillo, Vicente Moreno
Available online 11 July 2024
View all Ahead of print
Current Issue
Issue
Vol. 47. Issue 6.
Pages 553-672 (June - July 2024)
Original articles
Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study
Lidia Serrano Díaz, Carles Iniesta Navalón, Rosa Gómez Espín, Isabel Nicolás De Prado, Enrique Bernal Morell, Lorena Rentero Redondo
Gastroenterol Hepatol. 2024;47:553-61
Active alcohol consumption is associated with acute-on-chronic liver failure in Hispanic patients
Francisco Idalsoaga, Luis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, Francisco Valenzuela, Victor Meza, Franco Manzur, Joaquín Sotomayor, ... Juan Pablo Arab
Gastroenterol Hepatol. 2024;47:562-73
Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian pediatric patients: Real world experience
Viviana Parra-Izquierdo, Juan Sebastián Frías-Ordoñez, Carlos Cuadros, Melquicedec Vargas, José Fernando Vera Chamorro, Consuelo Romero Sanchez, Cristian Flórez-Sarmiento
Gastroenterol Hepatol. 2024;47:574-81
Colombian experience with the use of tofacitinib in severe acute ulcerative colitis: A case series study
Viviana Parra-Izquierdo, Juan Sebastián Frías-Ordoñez, Fabián Juliao-Baños, Carlos Cuadros, Consuelo Romero Sanchez, Cristian Flórez-Sarmiento
Gastroenterol Hepatol. 2024;47:582-90
View all issue
Free access article
Original article
Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study
Domingo Balderramo, Jesús Yamamoto-Furusho, Enrique Ponce de León, Julio de María, Ignacio Zubiaurre, Silvia Pedreira, Camilo Lis, Laura Brion, Juan A. de Paula
10.1016/j.gastre.2023.04.004
Gastroenterol Hepatol. 2024;47:51-62
Archive
View all archive
Instructions for authors
Most often read
Consensus document
Francisco Rodríguez-Moranta, Federico Argüelles-Arias, Joaquín Hinojosa del Val, Marisa Iborra Colomino, M. Dolores Martín-Arranz, Luis Menchén Viso, Fernando Muñoz Núñez, Elena Ricart Gómez, José Germán Sánchez-Hernández, Teresa Valdés-Delgado, Jordi Guardiola Capón, Manuel Barreiro-de Acosta, Míriam Mañosa Ciria, Yamile Zabana Abdo, Ana Gutiérrez Casbas
10.1016/j.gastre.2024.04.031
Gastroenterol Hepatol. 2024;47:522-52
This article has been read 228 times
View all Most Often read articles
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos